Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,061
datasets available to search
ShareScore release 0.9.0
Dataset results
5,061 results for “access”
Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer
ClinicalTrials.gov study NCT04504513. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism
ClinicalTrials.gov study NCT05654701. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access to Rovalpituzumab Tesirine
ClinicalTrials.gov study NCT03503890. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)
ClinicalTrials.gov study NCT01432483. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
ClinicalTrials.gov study NCT04100694. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
ClinicalTrials.gov study NCT07218224. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Individual Patient Esmethadone (REL-1017) Expanded Access Program
ClinicalTrials.gov study NCT06009003. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin
ClinicalTrials.gov study NCT05031546. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05757973. IPD Sharing: Not stated. Countries: 0. Publications: 0.
NRX-101 Expanded Access
ClinicalTrials.gov study NCT05779267. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST
ClinicalTrials.gov study NCT04148092. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC
ClinicalTrials.gov study NCT07399015. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion
ClinicalTrials.gov study NCT03206931. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments
ClinicalTrials.gov study NCT06004128. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung
ClinicalTrials.gov study NCT04507919. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Margetuximab Expanded Access Program
ClinicalTrials.gov study NCT03133988. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access to Navitoclax
ClinicalTrials.gov study NCT03592576. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease
ClinicalTrials.gov study NCT04540861. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor
ClinicalTrials.gov study NCT05225259. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Expanded Access Protocol for Mobocertinib in Refractory Non-small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Exon20 Insertion Mutations
ClinicalTrials.gov study NCT04535557. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.